KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Lifeward (LFWD) Research & Development (2016 - 2025)

Lifeward's Research & Development history spans 13 years, with the latest figure at $843000.0 for Q4 2025.

  • On a quarterly basis, Research & Development fell 25.46% to $843000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $3.2 million, a 29.75% decrease, with the full-year FY2025 number at $3.2 million, down 29.75% from a year prior.
  • Research & Development hit $843000.0 in Q4 2025 for Lifeward, up from $721000.0 in the prior quarter.
  • Over the last five years, Research & Development for LFWD hit a ceiling of $1.3 million in Q4 2023 and a floor of $638000.0 in Q3 2021.
  • Historically, Research & Development has averaged $949600.0 across 5 years, with a median of $912500.0 in 2022.
  • Biggest five-year swings in Research & Development: soared 71.68% in 2024 and later tumbled 36.35% in 2025.
  • Tracing LFWD's Research & Development over 5 years: stood at $696000.0 in 2021, then soared by 58.48% to $1.1 million in 2022, then increased by 19.49% to $1.3 million in 2023, then decreased by 14.19% to $1.1 million in 2024, then decreased by 25.46% to $843000.0 in 2025.
  • Business Quant data shows Research & Development for LFWD at $843000.0 in Q4 2025, $721000.0 in Q3 2025, and $767000.0 in Q2 2025.